Chief Scientific Officer Andreas Jeromin, Ph.D. “Our prognostic test will be an
essential tool to enhance drug development for ALS.” MDA has dedicated more
than $363 million to ALS research and support services since
... Pryazhnikov, Sarah K Coleman, Andreas Jeromin, Kari Keinänen and Leonard Khiroug* Neuroscience Center, University of Helsinki, FIN , Helsinki, Finland ... In the present study, we solved this problem by using repetitive ... To overcome these limitations, we set out to develop a method for ...
researchers advance blood biomarker capabilities that show changes ... "This
presents a unique opportunity to develop a mechanisms-based classification of
TBI in the context of personalized medicine," adds Andreas Jeromin, ...
for On- and Off-shore Wind. Authors; Authors and affiliations. Andreas Jeromin
Email author; A. Peter Schaffarczyk. Andreas Jeromin. 1. Email author; A. Peter
Schaffarczyk Forschungs- und Entwicklungszentrum FH Kiel GmbHKiel ...